Alliance Pharma Leadership

Alex Duggan is a Chief Commercial Officer at Alliance Pharma. He has worked as Head:Consumer Healthcare at Alliance Pharma. Alex attended University of Newcastle.

Andrew Franklin is a CFO/Executive Director at Alliance Pharma and Board Member at Alliance Pharma. He has worked as Finance Director/Secretary at Genzyme Therapeutics Ltd and Gen Mgr:European Tax & Accounting at Panasonic Europe Ltd.. Andrew attended Cardiff Metropolitan University.

Dan Thomas is a Chief Corporate Development Ofcr at Alliance Pharma. He has worked as Dir:Business Development at Alliance Pharma. Dan studied at Brunel University.

Janice Timberlake is a Chief People & Infrastructure Ofcr at Alliance Pharma. She has worked as Director:Human Resources at Alliance Pharma. Janice works or has worked as FELLOW at CIPD. She attended UNIVERSITY OF HULL.

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Alliance Pharma. Dr. Zhao has over 25 years of pharmaceutical industry experience with special focus on metabolic and pharmacokinetic properties of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Alliance Pharma, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade.

Dr. Zhao’s extensive experience spans the entire drug discovery and development process (discovery, development, and in-/out-licensing) in oncology, metabolic, antiviral, CNS, and inflammatory diseases. Dr. Zhao’s contributions and accomplishments of integrating in vitro and in vivo ADMET (absorption, distribution, metabolism, excretion, and toxicity) information to optimize drug candidate properties are documented in over 50 peer‑reviewed scientific publications and patents in the areas of new drug targets, drug metabolism, pharmacokinetics, and toxicology.

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and disposition. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia.

Andrew Franklin is a CFO/Executive Director at Alliance Pharma and Board Member at Alliance Pharma. He has worked as Finance Director/Secretary at Genzyme Therapeutics Ltd and Gen Mgr:European Tax & Accounting at Panasonic Europe Ltd.. Andrew attended Cardiff Metropolitan University.